Programmable preclinical study access

Mouse studies
for research sponsors

Translate a compound dossier and research question into a quote-ready mouse study plan: model assumptions, endpoints, sample handling, reporting level, and analysis-ready data delivery.

Run Lab Sim Request a study call

Research sponsor qualification COA, SDS, and lot intake IACUC / facility review path Signed report plus raw data

Operational view Overview

What this is

External mouse studies for teams that need data, not lab overhead.

InVivo API turns sponsor questions into supplier-ready study briefs for qualified external labs. We collect the compound dossier, research intent, model assumptions, endpoint package, documentation level, and data requirements so outsourced studies can move toward API-like ordering, tracking, and closeout over time.

Mouse-only Lab Sim Pick a compound and endpoint, then generate a gated draft study brief.

Run Lab Sim See inputs needed

Before we quote

What a serious study request needs before a lab can price it.

The fastest path to a real price is a complete research brief. If the model, strain, or assay package is not decided yet, the first call can focus on feasibility and narrow the design before supplier review.

Sponsor and use case

Organization, investigator contact, research-only purpose, billing path, confidentiality needs, and signed attestation before account setup.

Compound dossier

COA, SDS, lot number, purity, salt form, concentration, storage temperature, available material, and any formulation notes.

Research question

The decision the study should support, comparator ideas, target biology, must-have readouts, and what would make the result useful.

Animal and model assumptions

Mouse strain, sex, age range, diet or disease model, acclimation needs, group count, animals per group, and expected study duration.

Endpoint and sample map

Observations, body weight, food intake, clinical chemistry, plasma exposure, tissue collection, histology, or other assay panels.

Closeout format

Signed summary, raw XLSX/CSV, sample inventory, chain-of-custody notes, deviation log, images, and optional media when feasible.

Already know the compound and endpoint? Skip to Lab Sim

Study flow

A practical path from sponsor brief to closeout package.

Intake triage

Confirm sponsor identity, research-only use, compound dossier, target decision, budget range, and whether a mouse study is the right first step.

Feasibility review

Pressure-test model availability, animal welfare review path, assay feasibility, sample volume, material quantity, and logistics constraints.

Quote assumptions

Lock the quoted assumptions: groups, animals per group, duration, endpoint package, documentation level, turnaround, and required sponsor inputs.

Material startup

Coordinate compound receipt, storage conditions, inventory record, formulation assumptions, sample labels, and study calendar before first dosing.

Study operations

Track scheduled observations, sample collections, endpoint capture, facility notes, milestone updates, and deviations from the approved assumptions.

Closeout package

Deliver a signed report, endpoint tables, raw data exports, sample notes, and a follow-up review call.

Capabilities

Start with a narrow feasibility study or expand into a larger package.

Quote scope depends on the research decision, animal model, endpoint burden, assay availability, documentation level, and whether the sponsor needs exploratory data or a more formal package for diligence, publication, or regulated planning.

Tolerability and dose-range screen

Body weight, clinical observations, intake trends
Basic chemistry or hematology panels when needed
Useful for material triage before larger studies

PK / PD and exposure-response

Plasma or tissue collection schedule planning
LC-MS/MS or partner bioanalysis where feasible
Exposure tables aligned to endpoint trends

Metabolic and endocrine endpoints

Body weight, food intake, glucose, insulin, lipids
Diet, strain, sex, and duration assumptions reviewed
Designed for GLP-1 and metabolic-compound questions

Biomarker and blood chemistry panels

Clinical chemistry, cytokine, hormone, or custom panels
Sample-volume and assay-availability feasibility checks
Raw subject-level tables plus summary interpretation

Histology and pathology add-ons

Necropsy plan, tissue collection, fixation, staining
Image archive, scoring tables, and reviewer notes
Best added when tissue-level evidence matters

Custom endpoints and comparator studies

Neurobehavioral, repair, inflammation, or niche readouts
Comparator, vehicle, and lot-to-lot study structures
Scoped only after feasibility and ethics review

Use these packages as Lab Sim presets. Simulate a mouse study

Lab Sim

Generate a draft mouse study plan before the formal call.

Select a compound, study type, mouse count, duration, and deliverables. Lab Sim turns those inputs into a draft sponsor brief, feasibility checklist, sample map, and planning range that can be reviewed on a supplier call.

Simulation mode: the plan and pricing range are seeded from public facility and core-service ranges plus conservative CRO-style handling assumptions. It is a planning aid, not a live supplier quote.

Compound to test Start typing a peptide, GLP-1, small molecule, or custom compound. Mouse study type

Groups Mice per group

Study duration Documentation level

Add-ons LC-MS or exposure bioanalysis Blood chemistry or biomarker panel Necropsy, tissue collection, and histology Raw XLSX/CSV export and English summary Study photos, and short clips if feasible

Lab Sim preview

24 mice, 28-day mouse study

Run the simulation to watch the study planner reason through model fit, samples, documentation, and likely cost drivers.

Lab Sim outputs are planning artifacts, not final quotes. Species availability, mouse strain, model complexity, ethics review, assay method, compound handling, and rush timing can materially change price.

SEO study pages

Compound-specific pages for real study intent.

Open study index

GLP-1

Semaglutide animal studies

Scope exposure, tolerability, and metabolic endpoint packages.

GIP / GLP-1

Tirzepatide animal studies

Compare multi-agonist endpoint options and report formats.

Triple agonist

Retatrutide animal studies

Request feasibility, biomarker, and longitudinal data scoping.

Repair research

BPC-157 animal studies

Route exploratory endpoint requests through qualification.

Thymosin beta-4

TB-500 animal studies

Plan custom comparator, tolerability, and endpoint packages.

Neuropeptide

Semax animal studies

Discuss neuroscience-oriented endpoints and data delivery.

Data package

Useful to the scientist, finance team, and data team.

The closeout package should be readable by a scientist and useful to a data team. We scope the narrative report, raw tables, subject-level exports, sample inventory, and file naming before the study starts.

Study assumption sheet, facility notes, and final summary
Group-level and subject-level endpoint tables in XLSX/CSV
Sample inventory, timepoint map, and observation log exports
Chain-of-custody, deviation notes, and image archive when applicable

{
  "study_brief": {
    "compound": "retatrutide",
    "species": "mouse",
    "package": "exploratory_pk_pd",
    "review_path": "facility_and_ethics_review"
  },
  "deliverables": [
    "signed_summary_report",
    "subject_level_endpoint_tables",
    "sample_inventory",
    "raw_xlsx_csv_exports",
    "chain_of_custody_notes"
  ],
  "quote_status": "supplier_review_required"
}

Controls

Qualification protects the sponsor, the animals, and the study.

Sponsor qualification

Require organizational identity, research purpose, compound documentation, billing details, and signed research-use attestation before study planning.

Review path documented

Label each request as exploratory, GLP-aligned, or GLP-targeted and document facility, IACUC, welfare, and assay review gates before execution.

No human-use positioning

Keep public pages focused on preclinical research services, not consumer dosing, treatment claims, or compound sales.

Confidential data handling

Keep quote assumptions, material documents, source files, interim updates, and closeout exports in a controlled sponsor workspace when the account is approved.

Request a call

Send enough context for a real feasibility call.

Tell us the compound, what decision the study should support, what documentation exists, and whether the package is exploratory, diligence-facing, publication-oriented, or GLP-targeted.

Signed attestation before account setup COA, SDS, and material quantity requested during intake Protocol assumptions scoped after qualification

Name Work email

Phone number Organization

Compound Study stage

Model or endpoint Target timing

What do you need tested? I confirm this request is for authorized research use and is not seeking human-use dosing, treatment claims, or consumer sale support.